Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Hexo Corp - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS
Ticker
Exchange
SIC #
Website
Latest Ticker
HEXO
American
2833
https://www.hexocorp.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Hexo Corp
HEXO Ranks on The Globe and Mail’s Fourth-Annual Women Lead Here Benchmark of Executive Gender Diversity
- Mar 24th, 2023 1:15 pm
HEXO Corp. (NASDAQ:HEXO) Q2 2023 Earnings Call Transcript
- Mar 20th, 2023 2:02 am
HEXO Reports Q2’23 Financial Results
- Mar 16th, 2023 9:50 pm
HEXO to Host Second Quarter 2023 Earnings Conference Call
- Mar 14th, 2023 11:00 am
HEXO Increases Production of Its Popular Straight Edge Pre-Rolls and Launches Enhanced Inhalation Technology
- Feb 8th, 2023 12:00 pm
HEXO Announces Election of Directors
- Jan 31st, 2023 10:30 pm
HEXO Wins Complete Dismissal of Putative Québec Shareholder Class Action
- Jan 27th, 2023 12:00 pm
HEXO Corp. Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Jan 20th, 2023 12:00 pm
HEXO Corp. Announces Filing of Supplement to Proxy Circular for Appointment of Auditor
- Jan 13th, 2023 2:52 pm
HEXO Launches Five New Cannabis Strains Under Market-Leading Redecan and Original Stash Brands
- Jan 9th, 2023 12:00 pm
HEXO Reports Q1’23 Financial Results
- Dec 15th, 2022 12:07 pm
HEXO Corp Announces Share Consolidation
- Dec 14th, 2022 10:00 pm
HEXO Corp Announces Repayment of 8.0% Unsecured Convertible Debentures
- Dec 6th, 2022 12:30 pm
High Tide Becomes Top Revenue-Generating Cannabis Company in Canada
- Nov 22nd, 2022 11:00 am
Entourage Health Reports Third Quarter 2022 Financial Results and Posts $13.4 Million in Total Revenue
- Nov 15th, 2022 1:20 pm
HEXO and Entourage Health Sign Long-Term Supply Agreement
- Nov 15th, 2022 12:30 pm
HEXO Issues Correction to Press Release Announcing Q4’22 and FY22 Financial Results
- Nov 1st, 2022 10:52 pm
HEXO Announces Filing of Early Warning Report in Respect of the Former Zenabis Global Inc.
- Nov 1st, 2022 11:00 am
HEXO Reports Q4’22 and FY22 Financial Results
- Nov 1st, 2022 3:44 am
HEXO to Produce Mike Tyson’s New Cannabis Brand, TYSON 2.0, in Canada
- Aug 30th, 2022 11:00 am
Scroll